Health economic modeling for Alzheimer's disease: Expert perspectives
Abstract The successful development of an economic model for the evaluation of future Alzheimer's disease (AD) interventions is critical to accurately inform policy makers and payers. As our understanding of AD expands, this becomes an increasingly complex and challenging goal. Advances in diag...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/trc2.12360 |
| _version_ | 1826950788004446208 |
|---|---|
| author | Filipa Landeiro Jasmine Morton Anders Gustavsson Michele Potashman Pascal Lecomte Mark Belger Robin Thompson Emilse Roncancio‐Diaz Gurleen Jhuti Christopher Butler Linus Jönsson Ron Handels Alastair M. Gray the ROADMAP study |
| author_facet | Filipa Landeiro Jasmine Morton Anders Gustavsson Michele Potashman Pascal Lecomte Mark Belger Robin Thompson Emilse Roncancio‐Diaz Gurleen Jhuti Christopher Butler Linus Jönsson Ron Handels Alastair M. Gray the ROADMAP study |
| author_sort | Filipa Landeiro |
| collection | DOAJ |
| description | Abstract The successful development of an economic model for the evaluation of future Alzheimer's disease (AD) interventions is critical to accurately inform policy makers and payers. As our understanding of AD expands, this becomes an increasingly complex and challenging goal. Advances in diagnostic techniques for AD and the prospect of disease‐modifying treatments raise an urgent need to define specifications for future economic models and to ensure that the necessary data to populate them are available. This Perspective article provides expert opinions from health economists and governmental agency representatives on how future economic models for AD might be structured, validated, and reported. We aim to stimulate much‐needed discussion about the detailed specification of future health economic models for AD. |
| first_indexed | 2024-04-10T21:52:22Z |
| format | Article |
| id | doaj.art-8b096dbb28a34191a377db2b6db52ed4 |
| institution | Directory Open Access Journal |
| issn | 2352-8737 |
| language | English |
| last_indexed | 2025-02-17T22:37:18Z |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| spelling | doaj.art-8b096dbb28a34191a377db2b6db52ed42024-12-03T12:37:32ZengWileyAlzheimer’s & Dementia: Translational Research & Clinical Interventions2352-87372022-01-0181n/an/a10.1002/trc2.12360Health economic modeling for Alzheimer's disease: Expert perspectivesFilipa Landeiro0Jasmine Morton1Anders Gustavsson2Michele Potashman3Pascal Lecomte4Mark Belger5Robin Thompson6Emilse Roncancio‐Diaz7Gurleen Jhuti8Christopher Butler9Linus Jönsson10Ron Handels11Alastair M. Gray12the ROADMAP study13Health Economics Research Centre Nuffield Department of Population Health University of Oxford Oxford UKHealth Economics Research Centre Nuffield Department of Population Health University of Oxford Oxford UKDivision of Neurogeriatrics Department for Neurobiology Care Sciences and Society Karolinska Institutet Solna SwedenValue and Access, Biogen Cambridge Massachusetts USAGlobal Head Health Economic Modelling and Methodology Novartis Pharma AG Basel SwitzerlandGlobal Statistical Sciences Eli Lilly and Company Windlesham UKBiogen International GmbH Baar SwitzerlandGE Healthcare Life Sciences Amersham UKGlobal Access Centre of Excellence F. Hoffmannn‐La Roche Ltd. Basel SwitzerlandDepartment of Brain Sciences Imperial College London London UKDivision of Neurogeriatrics Department for Neurobiology Care Sciences and Society Karolinska Institutet Solna SwedenDivision of Neurogeriatrics Department for Neurobiology Care Sciences and Society Karolinska Institutet Solna SwedenHealth Economics Research Centre Nuffield Department of Population Health University of Oxford Oxford UKHealth Economics Research Centre Nuffield Department of Population Health University of Oxford Oxford UKAbstract The successful development of an economic model for the evaluation of future Alzheimer's disease (AD) interventions is critical to accurately inform policy makers and payers. As our understanding of AD expands, this becomes an increasingly complex and challenging goal. Advances in diagnostic techniques for AD and the prospect of disease‐modifying treatments raise an urgent need to define specifications for future economic models and to ensure that the necessary data to populate them are available. This Perspective article provides expert opinions from health economists and governmental agency representatives on how future economic models for AD might be structured, validated, and reported. We aim to stimulate much‐needed discussion about the detailed specification of future health economic models for AD.https://doi.org/10.1002/trc2.12360Alzheimer's diseasecostsdementiadisease‐modifying treatmenteconomic modelsmodel structure |
| spellingShingle | Filipa Landeiro Jasmine Morton Anders Gustavsson Michele Potashman Pascal Lecomte Mark Belger Robin Thompson Emilse Roncancio‐Diaz Gurleen Jhuti Christopher Butler Linus Jönsson Ron Handels Alastair M. Gray the ROADMAP study Health economic modeling for Alzheimer's disease: Expert perspectives Alzheimer’s & Dementia: Translational Research & Clinical Interventions Alzheimer's disease costs dementia disease‐modifying treatment economic models model structure |
| title | Health economic modeling for Alzheimer's disease: Expert perspectives |
| title_full | Health economic modeling for Alzheimer's disease: Expert perspectives |
| title_fullStr | Health economic modeling for Alzheimer's disease: Expert perspectives |
| title_full_unstemmed | Health economic modeling for Alzheimer's disease: Expert perspectives |
| title_short | Health economic modeling for Alzheimer's disease: Expert perspectives |
| title_sort | health economic modeling for alzheimer s disease expert perspectives |
| topic | Alzheimer's disease costs dementia disease‐modifying treatment economic models model structure |
| url | https://doi.org/10.1002/trc2.12360 |
| work_keys_str_mv | AT filipalandeiro healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT jasminemorton healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT andersgustavsson healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT michelepotashman healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT pascallecomte healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT markbelger healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT robinthompson healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT emilseroncanciodiaz healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT gurleenjhuti healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT christopherbutler healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT linusjonsson healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT ronhandels healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT alastairmgray healtheconomicmodelingforalzheimersdiseaseexpertperspectives AT theroadmapstudy healtheconomicmodelingforalzheimersdiseaseexpertperspectives |